Next Generation Commercial Innovation: Moving From Promise to Practice
Rohit Sood, EVP, COMPLETE Commercialization, EVERSANA Donald J. McCaffrey, President and CEO, Resverlogix Taren Grom, Co-Founder and Editor, PharmaVOICE (Moderator)
Leading commercialization and operational experts discuss why so many progressive pharma companies are focused on new commercial models that are agile and built on principles of operational excellence and renewable infrastructure in order to recognize significant resource and cost benefit. And while “innovative” seems to be the most over-utilized adjective to describe today’s commercialization efforts, our panelists break down the myths and discuss:
- How to turn away from fixed and sluggish structures to more efficient partnerships for success.
- How operational excellence during commercialization can ultimately benefit the patient.
- How to build an operation and a culture of agility that allows for rapid course correction to meet changing market needs.
- What the financial benefit of operational excellence is.
About the Sponsors
EVERSANA is the leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers and payers.
For more information please visit https://www.eversana.com